Genenta Science S.p.A. (Stock Symbol: GNTA)
is a leading company in the Life Sciences sector
, specifically operating within the Biological Products, (No Diagnostic Substances) industry.
.
The company has established itself as
an emerging investment opportunity with substantial growth potential.
Financial Performance & Key Metrics Analysis
Market Capitalization: $64 million - Classified as a
small-cap investment offering high growth potential.
Advanced AI Stock Prediction & Price Target Analysis
🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Genenta Science S.p.A. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.
Market Position & Competitive Advantage Analysis
Genenta Science S.p.A. strategically competes in the highly dynamic
Biological Products, (No Diagnostic Substances) marketplace,
representing an emerging small-cap investment with substantial growth potential and market disruption capabilities
.
.
Genenta Science S.p.A. Stock Price Chart and Technical Analysis
Loading chart data...
Loading Genenta Science S.p.A. interactive price chart and technical analysis...
Deep dive into Genenta Science S.p.A.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.
Understanding Valuation Metrics
What these metrics mean: Valuation metrics help determine if Genenta Science S.p.A. stock is fairly priced compared to its earnings, assets, and market position.
How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.
For Genenta Science S.p.A.:
P/B Ratio5.14x
Market Cap$64M
Book Value/Share$0.68
Understanding Profitability Metrics
What these metrics mean: These ratios measure how efficiently Genenta Science S.p.A. converts revenue into profit and generates returns for shareholders.
How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.
For Genenta Science S.p.A.:
Understanding Financial Health Metrics
What these metrics mean: These ratios assess Genenta Science S.p.A.'s ability to meet short-term obligations and manage debt levels effectively.
How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.
For Genenta Science S.p.A.:
Understanding Cash Flow Metrics
What these metrics mean: Cash flow metrics reveal Genenta Science S.p.A.'s ability to generate cash from operations and fund growth initiatives.
How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.
For Genenta Science S.p.A.:
Understanding Operational Efficiency Metrics
What these metrics mean: These ratios measure how effectively Genenta Science S.p.A. uses its assets and manages working capital.
How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.
For Genenta Science S.p.A.:
Understanding Financial Statement Data
What these metrics mean: Key figures from Genenta Science S.p.A.'s income statement and balance sheet showing absolute financial performance.
How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.
For Genenta Science S.p.A.:
Income Statement ($ Millions)
Balance Sheet Highlights ($ Millions)
Dividend & Shareholder Information
Shares Outstanding18M
Genenta Science S.p.A. (GNTA) Fundamental Analysis & Insider Trading Data
(Quarterly Financial Reports)
Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Genenta Science S.p.A. stock analysis.
Loading fundamental data...
Loading Genenta Science S.p.A. comprehensive fundamental analysis and insider trading data...
Milan, Italy and New York, New York-- (Newsfile Corp. - May 8, 2025) - Genenta Science, SpA (NASDAQ: GNTA), today announced its participation in the D. Boral Capital Inaugural Global Conference ...
News Genenta and Anemocyte announce a collaboration for the manufacturing of starting materials for cutting-edge cell-based therapies GlobeNewswireMay 7, 2025, 11:00:00 AM ...
MILAN and NEW YORK, March 19, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a pioneer in immuno-oncology and a leader in cell-based therapeutics, today announced a €20 million ($21.9 ...
Genenta Science, SpA, today announced its participation in the D. Boral Capital Inaugural Global Conference, taking place May 14, 2025, at The Plaza Hotel in New York City. To register for one-on ...
Our most recent data indicates that insiders own a reasonable proportion of Genenta Science S.p.A.. Insiders own US$30m worth of shares in the US$102m company.
See the top stocks recommended by analysts >> The company has a one-year high of $9.33 and a one-year low of $3.90. Currently, Genenta Science SpA Sponsored ADR has an average volume of 4,960.
Find out if Genenta Science SPA ADR (GNTA:XNAS) stock is overpriced or undervalued based on Morningstar's evaluation. Assess the current comparison of market prices to the Fair Value of the ...
Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. Its lead product candidate, Temferon, was developed using its ...
09:40 EST Genenta Science (GNTA) SPA (ADR) trading resumesDon't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium - Now At 40% OFF!Make smarter investments with ...
Comparative analysis of Genenta Science S.p.A. against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.
How accurate are Genenta Science S.p.A. stock predictions?
Our AI model demonstrates -41% historical accuracy for GNTA predictions, based on advanced machine learning algorithms trained on over 10 years of market data.
What factors influence Genenta Science S.p.A. stock price forecasts?
Is Genenta Science S.p.A. a good investment in 2025?
Based on our AI analysis, Genenta Science S.p.A. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.
How often are Genenta Science S.p.A. forecasts updated?
Genenta Science S.p.A. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.
Want More Advanced Genenta Science S.p.A. Analysis?
Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Genenta Science S.p.A. stock.
